• SENSEX 81,222.56
    -151.19 (--0.19%)
  • BANKNIFTY 55,903.40
    153.70 (+0.28%)
  • Yes Bank
    21.40 16.02(%)
  • Vodafone Idea
    6.75 6.46(%)
  • Aptus Value Hou.
    305.00 267.75(%)
  • Zinka Logistics
    420.00 248.25(%)
  • Bombay Dyeing
    159.05 256.25(%)
  • Ola Electric
    49.91 45.55(%)
  • Suzlon Energy
    68.51 45.13(%)
  • Reliance Power
    58.50 23.26(%)
  • Garden Reach Sh.
    3,076.45 3,143.00(%)
  • One 97
    951.95 1,063.00(%)
  • Mazagon Dock
    3,474.60 3,778.00(%)
  • Reliance Infra.
    337.05 143.70(%)
  • Cochin Shipyard
    1,995.00 2,977.10(%)
  • Eternal Ltd
    245.95 304.50(%)
  • Shilchar Tech.
    8,264.00 8,899.00(%)
  • KFin Technolog.
    1,170.00 1,640.00(%)
  • Trident
    33.09 41.79(%)
  • Cams Services
    4,223.10 5,367.45(%)
  • Adani Ports
    1,428.30 993.85(%)
  • H U D C O
    253.20 353.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7690.0
  • ISIN : INE858L01010
31.47 0 (-0.10%)
  • As on 03 Jun 2025 (EOD)

  • Today’s Low

    31.30

  • Today’s High

    32.79

  • Open

    32.79

  • Perv Close

    31.50

  • 52W Low

    26.10

  • 52W High

    44.96

Key Indicators

  • P/E(TTM)

    104.90

  • Mar.Cap (₹Cr.)

    31.47

  • Div & Yield %

    0.00

  • Book Value(₹)

    34.11

  • Debt-Equity Ratio

    -0.10

  • AGM Date

    02-Jun-2025

  • EPS

    0.30

  • P/E Ratio

    104.90

Financials Ratios

  • Debt-Equity Ratio

    0.53

  • Mar.Cap (₹Cr.)

    31.47

  • RONW (%)

    1.43

  • ROCE (%)

    4.76

Score Board

  • Equity (₹ in Cr.)

    10.00

  • BV (₹)

    34.10

  • Sales( ₹ in Cr.)

    36.93

  • NP (in Cr.)

    0.30

  • NP Var(%)

    -29.0

  • Div%

    0.0

  • CPS (₹)

    1.70

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    31.47

  • 52 Week High

    44.96

  • 52 Week Low

    26.10

  • Price BSE

    31.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    31.47

  • P/C Ratio

    18.10

  • P/E Ratio

    104.80

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 43.26 51.31 58.96 51.36 51.34 48.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 43.26 51.31 58.96 51.36 51.34 48.08
Other Income 0.01 0.01 0.10 3.86 0.12 0.09
Stock Adjustments 0.40 -0.52 2.31 -1.69 -0.52 -0.46
Total Income 43.67 50.80 61.37 53.53 50.94 47.71
EXPENDITURE :            
Raw Materials 33.71 40.36 44.41 41.28 42.06 39.14
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.77 0.78
Employee Cost 3.87 3.55 4.14 3.47 3.27 2.29
Other Manufacturing Expenses 0.39 0.44 0.43 0.60 0.40 0.41
Selling and Administration Expenses 1.81 2.05 1.52 1.03 0.95 0.77
Miscellaneous Expenses 0.21 0.06 5.19 0.07 0.04 0.58
Employee Benefit Expenses 3.87 3.55 4.14 3.47 3.27 2.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 39.99 46.46 55.67 46.45 47.48 43.96
Operating Profit 3.69 4.35 5.69 7.08 3.46 3.74
Interest 1.59 1.62 1.68 1.42 1.54 1.59
Gross Profit 2.10 2.73 4.01 5.66 1.92 2.15
Depreciation 1.54 1.60 1.76 1.37 1.46 1.71
Profit Before Tax 0.56 1.13 2.25 4.29 0.46 0.44
Current Tax 0.20 0.35 0.67 0.47 0.12 0.12
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.06 -0.11 -0.02 0.54 0.01 -0.08
Reported Net Profit 0.42 0.89 1.59 3.28 0.33 0.41
Extraordinary Items 0.00 0.00 0.00 2.88 0.00 0.00
Adjusted Net Profit 0.42 0.89 1.59 0.40 0.33 0.41
Adjustment below Net Profit 0.00 0.00 0.01 0.00 0.00 0.00
P & L Balance brought forward 14.40 13.51 11.91 8.63 8.30 7.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 14.82 14.40 13.51 11.91 8.63 8.30
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.42 0.96 1.82 3.75 0.38 0.52
Earnings Per Share(Adj)-Unit Curr 0.42 0.96 1.82 3.75 0.38 0.52
Book Value 33.82 33.43 32.44 30.61 26.86 29.45
Book Value(Adj)-Unit Curr 33.82 33.43 32.44 30.61 26.86 29.45

Shareholding Pattern

  • Promoter Group

    54.39%

  • Public Share Holding

    45.61%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,439,204 54.39 5,439,204 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,439,204 54.39 5,439,204 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 7,584 0.08 7,584 7
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 220,152 2.20 220,152 34
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,582,606 15.83 1,582,606 19
Individuals holding nominal share capital up to Rs. 1 lakh 2,750,454 27.50 2,159,054 5,189
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,560,796 45.61 3,969,396 5,249
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,000,000 100.00 9,408,600 5,252

Company Background

Concord Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Drugs Ltd
  • BSE Code : 7690.0
  • ISIN : INE858L01010

  • Incorporation Year

    1995

  • Registered Office

    Survey No 249 Brahmanapally V
    Hayathnagar M, Ranga Reddy,
    Telangana-501511

  • Telephone

    91-40-24036379

  • FAX

  • Chairman

    S Nagi Reddy

  • Managing Director

    S Nagi Reddy

  • Company Secretary

    Namratha Nagla

  • Auditor

    Pundarikashyam and Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

Concord Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Drugs 31.47 43.27 43.26 104.90 4.25
Abbott India 30,663.80 6,097.18 5,848.91 46.07 44.71
Astrazeneca Phar 9,315.65 1,330.33 1,295.53 201.20 33.26
P & G Health Ltd 5,758.05 1,166.89 1,151.26 38.05 39.76
Glaxosmi. Pharma 3,271.55 3,530.73 3,407.25 60.31 44.44
Cipla 1,469.75 17,645.00 16,574.34 23.02 20.10
Amrutanjan Healt 719.00 437.58 421.23 40.90 20.84
Fermenta Biotec. 318.15 315.24 307.09 13.85 4.10
Guj. Themis Bio. 309.40 174.19 169.82 69.06 44.82
Bliss GVS Pharma 133.80 638.96 605.46 20.43 11.19
Ambalal Sarabhai 37.10 11.70 3.81 34.35 1.92